Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma

Molecular and Cellular Biochemistry

Volumn 347, Issue 1-2, 2011, Pages 201-208

  Akkız, Hikmet ^a   Bayram, Süleyman ^a,b   Bekar, Aynur ^a   Akgöllü, Ersin ^a   Ülger, Yakup ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

Case control study; COX 2 1195 A>G (rs689466) polymorphism; COX 2 765G>C (rs20417) polymorphism; Genetic susceptibility; Hepatocellular carcinoma

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX RATIO; SMOKING;

EID: 78651320787     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0629-9     Document Type: Article

References (34)

1. DL De Witt 1991 Prostaglandin endoperoxide synthase: regulation of enzyme expression Biochim Biophys Acta 1083 121 134 10.1016/0005-2760(91)90032-D
2. NV Chandrasekharan DL Simmons 2004 The cyclooxygenases Genom Biol 5 241 10.1186/gb-2004-5-9-241 1:CAS:528:DC%2BD2cXot1WntLs%3D 10.1186/gb-2004-5-9-241 (Pubitemid 39335025)
3. TD Warner JA Mitchell 2002 Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA 99 13371 13373 10.1073/pnas.222543099 1:CAS:528:DC%2BD38XotVKnu74%3D 10.1073/pnas.222543099 12374850 (Pubitemid 35215385)
4. CS Williams M Mann RN DuBois 1999 The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 7908 7916 1:CAS:528: DC%2BD3cXks1KlsA%3D%3D 10.1038/sj.onc.1203286 10630643
5. OC Trifan T Hla 2003 Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis J Cell Mol Med 7 207 222 10.1111/j.1582-4934.2003. tb00222.x 1:CAS:528:DC%2BD2MXltVWrtb4%3D 10.1111/j.1582-4934.2003.tb00222.x 14594546
6. RA Soslow AJ Dannenberg D Rush BM Woerner KN Khan J Masferrer AT Koki 2000 Cox-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 2637 2645 10.1002/1097-0142(20001215) 1:CAS:528:DC%2BD3MXitFWisw%3D%3D 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B 11135226
7. AT Koki JL Masferrer 2002 Celecoxib: a specific COX-2 inhibitor with anticancer properties Cancer Control 9 28 35 11965228
8. G Gasparini R Longo R Sarmiento A Morabito 2003 Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4 605 615 10.1016/S1470-2045(03)01220-8 1:CAS:528:DC%2BD3sXnvVKksbo%3D 10.1016/S1470-2045(03)01220-8 14554238 (Pubitemid 37258402)
9. T Wu 2006 Cyclooxygenase-2 in hepatocellular carcinoma Cancer Treat Rev 32 28 44 10.1016/j.ctrv.2005.10.004 1:CAS:528:DC%2BD28XhtFWgsrY%3D 10.1016/j.ctrv.2005.10.004 16337744 (Pubitemid 43159775)
10. R Tazawa XM Xu KK Wu LH Wang 1994 Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene Biochem Biophys Res Commun 203 190 199 10.1006/bbrc.1994.2167 1:CAS:528:DyaK2cXlvFOnsro%3D 10.1006/bbrc.1994.2167 8074655 (Pubitemid 24281079)
11. SB Appleby A Ristimaki K Neilson K Narko T Hla 1994 Structure of the human cyclo-oxygenase-2 gene Biochem J 302 723 727 1:CAS:528: DyaK2MXntlGjtw%3D%3D 7945196
12. A Papafili MR Hill DJ Brull RJ McAnulty RP Marshall SE Humphries GJ Laurent 2002 Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 1631 1636 10.1161/01.ATV.0000030340.80207.C5 1:CAS:528:DC%2BD38XnsVKrtr8%3D 10.1161/01.ATV.0000030340.80207.C5 12377741
13. W Szczeklik M Sanak A Szczeklik 2004 Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma J Allergy Clin Immunol 114 248 253 10.1016/j.jaci.2004.05.030 1:CAS:528:DC%2BD2cXotVeis7s%3D 10.1016/j.jaci.2004.05.030 15316498 (Pubitemid 39119020)
14. X Zhang X Miao W Tan B Ning Z Liu Y Hong W Song Y Guo X Zhang Y Shen B Qiang FF Kadlubar D Lin 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565 576 10.1053/j.gastro.2005.05.003 1:CAS:528: DC%2BD2MXpvVWmsbw%3D 16083713
15. RG Ramsay A Friend Y Vizantios R Freeman C Sicurella F Hammett J Armes D Venter 2000 Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB Cancer Res 60 1805 1809 1:CAS:528: DC%2BD3cXisVyntbo%3D 10766162
16. SJ Cok AR Morrison 2001 The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency J Biol Chem 276 23179 23185 10.1074/jbc.M008461200 1:CAS:528:DC%2BD3MXkvValsrs%3D 10.1074/jbc.M008461200 11294846
17. W Zhu BB Wei X Shan P Liu 2009 765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies Mol Biol Rep 37 1 277 288 10.1007/s11033-009-9685-1 10.1007/s11033-009-9685-1 19669667
18. J Bruix M Sherman JM Llovet M Beaugrand R Lencioni AK Burroughs E Christensen L Pagliaro M Colombo J Rodés 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 1:STN:280:DC%2BD3MrksFCmtg%3D%3D 10.1016/S0168-8278(01)00130-1 11592607 (Pubitemid 32844200)
19. JF Tsai WY Chang JE Jeng MS Ho ZY Lin JH Tsai 1994 Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study Liver 14 98 102 1:STN:280:DyaK2c3lsVKktw%3D%3D 7515142
20. RN Pugh IM Murray-Lyon JL Dawson MC Pietroni R Williams 1973 Transection of the esophagus for bleeding esophageal varices Br J Surg 60 646 649 1:STN:280:DyaE3s3jsVWqsw%3D%3D 10.1002/bjs.1800600817 4541913
21. J Gao Q Ke HX Ma Y Wang Y Zhou ZB Hu XJ Zhai XC Wang JW Qing WS Chen GF Jin JY Liu YF Tan XR Wang HB Shen 2007 Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population J Toxicol Environ Health A 70 908 915 10.1080/15287390701289966 10.1080/15287390701289966 17479405 (Pubitemid 46699715)
22. H Akkiz S Bayram A Bekar B Ozdil E Akgöllü AT Sümbül H Demiryürek F Doran 2009 G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study Cancer Epidemiol 33 3-4 261 264 10.1016/j.canep.2009.06.001 1:CAS:528:DC%2BD1MXhsFKjs7zP 10.1016/j.canep.2009.06.001 19683483
23. H Akkiz S Bayram A Bekar E Akgöllü B Ozdil 2010 Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma J Viral Hepat 17 668 674 10.1111/j.1365-2893.2009. 01225.x 1:STN:280:DC%2BC3cjls1Gqtg%3D%3D 20002563
24. T Chi-Man Tang R Tung-Ping Poon ST Fan 2005 The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma Biomed Pharmacother 59 S311 S316 10.1016/S0753-3322(05)80053-8 10.1016/S0753-3322(05) 80053-8 16507400
25. M Oshima JE Dinchuk SL Kargman H Oshima B Hancock E Kwong JM Trzaskos JF Evans MM Taketo 1996 Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 809 10.1016/S0092-8674(00)81988-1 1:CAS:528:DyaK28XntlymsLc%3D 10.1016/S0092- 8674(00)81988-1 8945508 (Pubitemid 26404280)
26. JN Hirschhorn K Lohmueller E Byrne K Hirschhorn 2002 A comprehensive review of genetic association studies Genet Med 4 45 61 1:CAS:528: DC%2BD38XjtFSru7w%3D 10.1097/00125817-200203000-00002 11882781 (Pubitemid 44698579)
27. G Shaw R Kamen 1986 A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell 46 659 667 10.1016/0092-8674(86)90341-7 1:CAS:528:DyaL28Xls1KitrY%3D 10.1016/0092-8674(86)90341-7 3488815
28. D Caput B Beutler K Hartog R Thayer S Brown-Shimer A Cerami 1986 Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators Proc Natl Acad Sci USA 83 1670 1674 1:CAS:528:DyaL28XktF2lsbw%3D 10.1073/pnas.83.6.1670 2419912
29. K Cartharius K Frech K Grote B Klocke M Haltmeier A Klingenhoff M Frisch M Bayerlein T Werner 2005 MatInspector and beyond: promoter analysis based on transcription factor binding sites Bioinformatics 21 2933 2942 10.1093/bioinformatics/bti473 1:CAS:528:DC%2BD2MXmt1yrtrc%3D 10.1093/bioinformatics/bti473 15860560 (Pubitemid 40916416)
30. IL Hofacker 2003 Vienna RNA secondary structure server Nucleic Acids Res 31 3429 3431 1:CAS:528:DC%2BD3sXltVWisrs%3D 10.1093/nar/gkg599 12824340 (Pubitemid 37442172)
31. R Upadhyay M Jain S Kumar UC Ghoshal B Mittal 2009 Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squamous cell carcinoma Mutat Res 26 663 52 59 10.1016/j.mrfmmm.2009.01.007
32. K Srivastava A Srivastava SN Pandey A Kumar B Mittal 2009 Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population J Gastroenterol 44 774 780 10.1007/s00535-009- 0071-5 1:CAS:528:DC%2BD1MXotleht7o%3D 10.1007/s00535-009-0071-5 19455278
33. J Shi NL Misso MA Kedda J Horn MD Welch DL Duffy C Williams PJ Thompson 2008 Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G>A promoter polymorphism with mild asthma Clin Exp Allergy 38 913 920 10.1111/j.1365-2222.2008.02986.x 1:CAS:528: DC%2BD1cXotVOhtL4%3D 10.1111/j.1365-2222.2008.02986.x 18489027 (Pubitemid 351725859)
34. D Wang RN Dubois 2006 Prostaglandins and cancer Gut 55 115 122 10.1136/gut.2004.047100 1:CAS:528:DC%2BD28Xnt1yquw%3D%3D 10.1136/gut.2004.047100 16118353 (Pubitemid 41820645)